RESEARCHER PROFILE
Assoc Professor Cedric Bardy, SAHMRI (2023)
Director of The Laboratory for Human Neurophysiology, Genetics & Stem Cells
South Australian Health and Medical Research Institute (SAHMRI) &
Professor, Flinders University
Adelaide, South Australia
Filmed November 2023
Associate Professor Cedric Bardy is the Director of The Laboratory for Human Neurophysiology, Genetics & Stem Cells, located at SAHMRI. South Australia.
His current research uses preclinical, patient-derived cell models to test innovative therapeutic strategies, with a current focus on Parkinson’s disease, brain cancer and childhood dementia (Sanfilippo syndrome).
His work has established a platform to facilitate the discovery and validation of treatments for brain disorders. Their research is at the frontier of human cellular neuroscience research and translational applications that benefit global public health.
In particular, Cedric is the inventor of BrainPhys; a neuronal medium broadly used to culture human neurons in vitro, commercialised by STEMCELL Technologies.
The ability to grow human brain cells in a petri dish opens up new possibilities for research and discovery in neuroscience.
The BrainPhys medium allows human brain cells to function as they would in the adult human brain, revolutionizing research in labs across the world.
Cedric Bardy’s research enables researchers to study human brain disorders in a more physiological context, potentially leading to new treatments for brain cancer, Parkinson’s disease, and Sanfilippo Syndrome.
Cedric Bardy’s international journey from France to Canada to Australia and then to the United States showcases the global nature of scientific research and collaboration.
The passion for neuroscience stems from the fact that everything we care about as humans is influenced by brain activity.
Cedric Bardy is passionate about finding ways to treat the brain when things go wrong, showing a deep commitment to neurological research.
-
Identification & characterisation of molecular drivers of therapeutic resistance
Professor Pieter Eichhorn is an internationally experienced cancer biologist and research leader whose career has been defined by high-impact contributions at the interface of functional genomics, translational oncology, and research infrastructure strategy.
He completed his PhD at the University of Newcastle upon Tyne, contributing to the cloning of the gene associated with Cornelia de Lange Syndrome, before undertaking postdoctoral training at the Netherlands Cancer Institute in the laboratory of René Bernards. There, he performed pioneering functional genetic screens that identified key regulators of oncogenesis and therapy resistance, including critical roles for the PI3K signalling pathway in resistance to targeted breast cancer therapies.
-
Electrical stimulation on organic conductors
Professor Gordon Wallace AO is the Founder and Director of the Intelligent Polymer Research Institute (IPRI) at the University of Wollongong and Founding Director of the Australian National Fabrication Facility (ANFF) Materials Node. He was previously the Executive Director of the ARC Centre of Excellence for Electromaterials Science (ACES).
-
CASE STUDY High blood pressure and shorter sleep may worsen brain decline
People with high blood pressure who also lack sleep may be at increased risk of reduced cognitive performance and greater brain injury, Monash University research has found.
Published in the Journal of the American Heart Association, researchers assessed whether the combined effect of hypertension and short sleep duration had a negative impact on brain health.
